benchtop genome synthesis device

32 views
Skip to first unread message

Jonathan Cline

unread,
Jun 13, 2012, 1:41:51 AM6/13/12
to enzymatic...@googlegroups.com, jcline

quote

Kettner Griswold (19, Bethesda, MD) and Paul Sebexen (19, Staten Island, NY) are stopping out of school to work on a benchtop genome synthesis device, which will allow individual laboratories and medical practices to synthesize large genetic constructs in-house for an unprecedented low recurring cost. This product would massively disrupt the fields of biotechnology and health care, fueling innovation and stimulating interest and research sector-wide.

endquote

http://www.forbes.com/sites/briancaulfield/2012/06/13/facebooks-first-investor-pays-twenty-more-people-to-skip-school


## Jonathan Cline
## jcl...@ieee.org
## Mobile: +1-805-617-0223
########################

Bryan Bishop

unread,
Jun 13, 2012, 10:54:24 AM6/13/12
to enzymatic...@googlegroups.com, Bryan Bishop
On Wed, Jun 13, 2012 at 12:41 AM, Jonathan Cline <jnc...@gmail.com> wrote:
Kettner Griswold (19, Bethesda, MD) and Paul Sebexen (19, Staten Island, NY) are stopping out of school to work on a benchtop genome synthesis device, which will allow individual laboratories and medical practices to synthesize large genetic constructs in-house for an unprecedented low recurring cost. This product would massively disrupt the fields of biotechnology and health care, fueling innovation and stimulating interest and research sector-wide.

I have some inside scoops on Kettner/that guy, and he's already pivoted to something else.

--
- Bryan
http://heybryan.org/
1 512 203 0507
Reply all
Reply to author
Forward
0 new messages